ArticleHepatobiliary surgery and nutrition2025

Transarterial chemoembolization combined with immunotherapy plus bevacizumab or lenvatinib for the treatment of unresectable hepatocellular carcinoma: which treatment strategy demonstrates superior efficacy?

Wendi Kang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.